JOHN PENCE

Senate and house appropriations and rules committees for housing affordability funding for FY27.

Advocated for federal investment in artificial intelligence and autonomous logistics technologies to support the Department of Defenses modernization initiatives, including enhanced situational awareness and predictive supply chain capabilities. Discussions included provisions in the National Defense Authorization Act (NDAA) for FY2025 relating to emerging technology procurement, DIU contracting flexibility, and strategic sourcing initiatives for battlefield autonomy solutions. Engaged with congressional staff and executive agencies to promote AI integration in military logistics and national security infrastructure.

Homeland security, border security, defense readiness, advanced screening technologies, border infrastructure, threat detection, and related DHS, CBP, TSA, DOD, White House, and congressional policies, programs, procurement, and appropriations.

Homeland security, border security, defense readiness, advanced screening technologies, border infrastructure, threat detection, and related DHS, CBP, TSA, DOD, White House, and congressional policies, programs, procurement, and appropriations.

Homeland security, border security, defense readiness, advanced screening technologies, border infrastructure, threat detection, and related DHS, CBP, TSA, DOD, White House, and congressional policies, programs, procurement, and appropriations.

Lobbying in support of passage of the SAVE America Act, including provisions related to federal election integrity, voter registration requirements, and related administrative procedures.

Public safety funding, emergency response coordination, and urban security initiatives affecting the City of Gresham, including DHS grant programs and federal-local coordination policies.

Support for civil nuclear technologies for heavy industry, maritime, and transportation in the FY 2027 National Defense Authorization Act and several sections of the FY 2027 Appropriations Act.

Support for civil nuclear technologies for heavy industry, maritime, and transportation in the FY 2027 National Defense Authorization Act and several sections of the FY 2027 Appropriations Act.

Advocated for clarity and fairness in the regulation of pharmaceutical compounding by the Food and Drug Administration (FDA), including issues related to compliance with Sections 503A and 503B of the Federal Food, Drug, and Cosmetic Act.

Advocated for regulatory clarity and proportional enforcement in the oversight of outsourcing facility manufacturing under Section 503B of the Federal Food, Drug, and Cosmetic Act.

Senate and house appropriations and rules committees for housing affordability funding for FY27.

Advocated for federal investment in artificial intelligence and autonomous logistics technologies to support the Department of Defenses modernization initiatives, including enhanced situational awareness and predictive supply chain capabilities. Discussions included provisions in the National Defense Authorization Act (NDAA) for FY2025 relating to emerging technology procurement, DIU contracting flexibility, and strategic sourcing initiatives for battlefield autonomy solutions. Engaged with congressional staff and executive agencies to promote AI integration in military logistics and national security infrastructure.

Lobbying in support of passage of the SAVE America Act, including provisions related to federal election integrity, voter registration requirements, and related administrative procedures.

Public safety funding, emergency response coordination, and urban security initiatives affecting the City of Gresham, including DHS grant programs and federal-local coordination policies.

Support for civil nuclear technologies for heavy industry, maritime, and transportation in the FY 2027 National Defense Authorization Act and several sections of the FY 2027 Appropriations Act.

Support for civil nuclear technologies for heavy industry, maritime, and transportation in the FY 2027 National Defense Authorization Act and several sections of the FY 2027 Appropriations Act.

Advocated for clarity and fairness in the regulation of pharmaceutical compounding by the Food and Drug Administration (FDA), including issues related to compliance with Sections 503A and 503B of the Federal Food, Drug, and Cosmetic Act.

Advocated for regulatory clarity and proportional enforcement in the oversight of outsourcing facility manufacturing under Section 503B of the Federal Food, Drug, and Cosmetic Act.

Senate and house appropriations and rules committees for housing affordability funding for FY27.

Advocated for federal investment in artificial intelligence and autonomous logistics technologies to support the Department of Defenses modernization initiatives, including enhanced situational awareness and predictive supply chain capabilities. Discussions included provisions in the National Defense Authorization Act (NDAA) for FY2025 relating to emerging technology procurement, DIU contracting flexibility, and strategic sourcing initiatives for battlefield autonomy solutions. Engaged with congressional staff and executive agencies to promote AI integration in military logistics and national security infrastructure.

H.R. 7296 / S. 1383 - SAVE America Act (Safeguard American Voter Eligibility Act). Lobbying in support of passage requiring documentary proof of U.S. citizenship to register to vote in federal elections and related election integrity provisions.

H.R. 7296 / S. 1383 - SAVE America Act (Safeguard American Voter Eligibility Act). Lobbying in support of passage requiring documentary proof of U.S. citizenship to register to vote in federal elections and related election integrity provisions.

Matters related to federal homeland security programs, including Department of Homeland Security grant programs, emergency management funding, infrastructure protection, and related federal policy affecting municipal public safety and resilience.

Nuclear technology and energy.

Nuclear technology and energy.

Nuclear technology and energy.

Agricultural appropriations: issues related to the hemp industry.

Advocated for clarity and fairness in the regulation of pharmaceutical compounding by the Food and Drug Administration (FDA), including issues related to compliance with Sections 503A and 503B of the Federal Food, Drug, and Cosmetic Act.

Advocated for regulatory clarity and proportional enforcement in the oversight of outsourcing facility manufacturing under Section 503B of the Federal Food, Drug, and Cosmetic Act.

Senate and house appropriations and rules committees for housing affordability funding for FY26.

Advocated for federal investment in artificial intelligence and autonomous logistics technologies to support the Department of Defenses modernization initiatives, including enhanced situational awareness and predictive supply chain capabilities. Discussions included provisions in the National Defense Authorization Act (NDAA) for FY2025 relating to emerging technology procurement, DIU contracting flexibility, and strategic sourcing initiatives for battlefield autonomy solutions. Engaged with congressional staff and executive agencies to promote AI integration in military logistics and national security infrastructure.

(1) H.R. 5371 Opposition: Remove hemp-restricting language in H.R. 5371 threatening $28B industry. Lobby House/Senate Appropriations and Members. (2) Pro-Hemp Standards: Advocate age-21+ verification, testing, and USDA/FDA rules. Engage House/Senate Agriculture, USDA, FDA, DEA. (3) Hemp Economic Protection: Secure banking access, address tax issues. Target House Financial Services, Senate Banking, Treasury as applicable.

(1) H.R. 5371 Opposition: Remove hemp-restricting language in H.R. 5371 threatening $28B industry. Lobby House/Senate Appropriations and Members. (2) Pro-Hemp Standards: Advocate age-21+ verification, testing, and USDA/FDA rules. Engage House/Senate Agriculture, USDA, FDA, DEA. (3) Hemp Economic Protection: Secure banking access, address tax issues. Target House Financial Services, Senate Banking, Treasury as applicable.

Advocacy before HUD, the Executive Office of the President, and congressional housing committees regarding affordable and workforce housing policies, rent adjustment approvals, and regulatory reforms to expand private investment in HUD-assisted and LIHTC properties on behalf of client.

Advocated for regulatory clarity and proportional enforcement in the oversight of outsourcing facility manufacturing under Section 503B of the Federal Food, Drug, and Cosmetic Act.

Advocated for clarity and fairness in the regulation of pharmaceutical compounding by the Food and Drug Administration (FDA), including issues related to compliance with Sections 503A and 503B of the Federal Food, Drug, and Cosmetic Act.

Senate and house appropriations and rules committees for housing affordability funding for FY26.

Advocated for federal investment in artificial intelligence and autonomous logistics technologies to support the Department of Defenses modernization initiatives, including enhanced situational awareness and predictive supply chain capabilities. Discussions included provisions in the National Defense Authorization Act (NDAA) for FY2025 relating to emerging technology procurement, DIU contracting flexibility, and strategic sourcing initiatives for battlefield autonomy solutions. Engaged with congressional staff and executive agencies to promote AI integration in military logistics and national security infrastructure.

Issues relating to HUD affordable and multifamily housing programs, including financing and regulatory matters; Department of the Interior land use and permitting affecting real estate development; and Executive Branch policies impacting housing, infrastructure, and property development.

Issues relating to HUD affordable and multifamily housing programs, including financing and regulatory matters; Department of the Interior land use and permitting affecting real estate development; and Executive Branch policies impacting housing, infrastructure, and property development.

Advocated for clarity and fairness in the regulation of pharmaceutical compounding by the Food and Drug Administration (FDA), including issues related to compliance with Sections 503A and 503B of the Federal Food, Drug, and Cosmetic Act.

Advocated for regulatory clarity and proportional enforcement in the oversight of outsourcing facility manufacturing under Section 503B of the Federal Food, Drug, and Cosmetic Act.

Senate and house appropriations and rules committees for housing affordability funding for FY26.

Advocated for federal investment in artificial intelligence and autonomous logistics technologies to support the Department of Defenses modernization initiatives, including enhanced situational awareness and predictive supply chain capabilities. Discussions included provisions in the National Defense Authorization Act (NDAA) for FY2025 relating to emerging technology procurement, DIU contracting flexibility, and strategic sourcing initiatives for battlefield autonomy solutions. Engaged with congressional staff and executive agencies to promote AI integration in military logistics and national security infrastructure.

Lobbying federal agencies and Congress on digital access, mobile broadband expansion, consumer protection rules, and regulatory impacts on ad-supported mobile platforms enabling income generation through smartphone-based digital engagement.

Lobbying federal agencies and Congress on digital access, mobile broadband expansion, consumer protection rules, and regulatory impacts on ad-supported mobile platforms enabling income generation through smartphone-based digital engagement.

Lobbying federal agencies and Congress on digital access, mobile broadband expansion, consumer protection rules, and regulatory impacts on ad-supported mobile platforms enabling income generation through smartphone-based digital engagement.

Senate and house appropriations and rules committees for housing affordability funding for FY26.

Engage with federal agencies, members of Congress and congressional committees impacting pharmaceutical compounding and patient health issues.

Engage with federal agencies, members of Congress and congressional committees impacting pharmaceutical compounding and patient health issues.

Engage with federal agencies, members of Congress and congressional committees impacting pharmaceutical compounding and patient health issues.

Engage with federal agencies, members of Congress and congressional committees on housing and appropriations funding for priority areas.

Engage with federal agencies, members of Congress and congressional committees on housing and appropriations funding for priority areas.

Engage with federal agencies, members of Congress and congressional committees on housing and appropriations funding for priority areas.

FinTech and blockchain related policy and regulatory issues.

FinTech and blockchain related policy and regulatory issues.

Engage with federal agencies, members of Congress and congressional committees on homeland security, armed services, authorization and funding for priority areas, Defense Appropriations, NDAA.

Engage with federal agencies, members of Congress and congressional committees on homeland security, armed services, authorization and funding for priority areas, Defense Appropriations, NDAA.

Engage with federal agencies, members of Congress and congressional committees on homeland security, armed services, authorization and funding for priority areas, Defense Appropriations, NDAA.

Government Relations Services regarding digital assets and crypto currencies.

Government Relations Services regarding digital assets and crypto currencies.